Company profile: ProPharma
1.1 - Company Overview
Company description
- Provider of independent, single-source regulatory, compliance, pharmacovigilance, and medical information services for pharmaceutical, biotechnology, and medical device companies; offering RCO custom solutions across the full product lifecycle, tailored MedTech solutions from concept to market, full-service Oncology CRO capabilities, global lifecycle solutions, and Prodigy technology to de-risk decision making and drive value.
Products and services
- Global Solutions: full-lifecycle services that orchestrate end-to-end support spanning the entire product lifecycle, focused on solving complex challenges in dynamic environments
- Prodigy: Enabling Technology: technology-driven suite that de-risks decision making and drives value, delivering integrated products architected to inform and streamline complex decisions
- RCO: custom-engineered model delivering regulatory, compliance, and consulting services across the full product lifecycle, creating tailored assemblies aligned to program requirements
Key contacts
🔒
🔒
Financial details
🔒
1.2 - Competitors and similar companies to ProPharma
Phaxiam Therapeutics
HQ: France
Website
- Description: Provider of bacteriophage-based therapies to combat antimicrobial-resistant bacterial infections, offering phage treatments, GMP individualized phage therapies (IPT), standardized phage therapies medicinal products (PTMP), a phage portfolio targeting Staphylococcus aureus, Escherichia coli and Pseudomonas aeruginosa, an in vitro Phagogram test for phage susceptibility, and PhagoDAIR clinical trial.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Phaxiam Therapeutics company profile →
Kentucky Clinical Trials Laboratory
HQ: United States
Website
- Description: Provider of pharmaceutical and diagnostic clinical trials, specimen collection, and medical studies to support research, development, and regulatory transition of novel products in medicine for business organizations.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Kentucky Clinical Trials Laboratory company profile →
Nucleis
HQ: Belgium
Website
- Description: Provider of radiopharmaceutical drugs, manufacturing and distributing generic radiopharmaceuticals for clinical oncology, cardiology, neurology, infectious and inflammatory diseases. It aims to develop new diagnostic tools, support innovative therapies, and distributes radiopharmaceutical drugs dedicated to Positron Emission.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Nucleis company profile →
Patheon
HQ: United States
Website
- Description: Provider of commercial manufacturing and pharmaceutical development services to pharmaceutical and biotechnology industries worldwide, spanning solid, semi-solid, liquid, and sterile dosage forms. Offers contract development and manufacturing from preclinical to commercialization, clinical trial strategy and operations, commercial services, advanced therapies (viral vectors, cell therapy, mRNA), biologics, and small molecule development and manufacturing.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Patheon company profile →
CSL
HQ: United States
Website
- Description: Provider of quality system, risk management, support, and consulting services.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full CSL company profile →
🔒
2.M&A buyers
2.1 Potential strategic acquirers in the sector
🔒
🔒
🔒
🔒
View all strategic buyers with complete profiles
Start Free Trial →
2.2 - Strategic buyer groups for ProPharma
🔒
Buyer group 1: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 2: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 3: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →
3. Investors and private equity firms
3.1 - Buyout funds investing in similar companies to ProPharma
2.2 - Growth funds investing in similar companies to ProPharma
🔒
View all growth equity funds with complete profiles
Start Free Trial →
4 - Top valuation comps for ProPharma
4.2 - Public trading comparable groups for ProPharma
🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →